Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Sulfobutyl Ether Beta-Cyclodextrin Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    27/02/2026 Hainan Poly Pharm
    China
    		 ANHUI POLY PHARMACEUTICAL COMPANY LIMITED Anqing CN CEP 2022-504 - Rev 00 Sulfobutylbetadex sodium 2024-07-03 Valid Chemical 2804
    27/02/2026 Shandong Binzhou Zhiyuan Biotechnology Co.Ltd
    China
    		 SHANDONG BINZHOU ZHIYUAN BIOTECHNOLOGY CO., LTD Binzhou City CN CEP 2024-406 - Rev 00 Sulfobutylbetadex sodium 2026-02-04 Valid Chemical 2804
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.